In the BioHarmony Drug Report Database

"Preview" Icon

Palonosetron

Aloxi, Palonosetron (palonosetron) is a small molecule pharmaceutical. Palonosetron was first approved as Aloxi on 2003-07-25. It has been approved in Europe to treat nausea, neoplasms, and vomiting. The pharmaceutical is active against 5-hydroxytryptamine receptor 3A. Aloxi’s patent is valid until 2024-01-30 (FDA).

 

Trade Name

 

Aloxi
 

Common Name

 

palonosetron
 

ChEMBL ID

 

CHEMBL1189679
 

Indication

 

nausea, neoplasms, vomiting
 

Drug Class

 

Serotonin 5-HT3 antagonists

Image (chem structure or protein)

Palonosetron structure rendering